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The "TERM" concept (Tissue Engineering and Regenerative Medicine) is the result of an evolution performed by the field of tissue engineering. It can be defined as a rapidly 
growing interdisciplinary field involving life, physical and engineering sciences and seeking to develop clinical therapies for the repair, maintenance, replacement and/or 
enhancement of biological function. 
A very important role in TERM is played by biomaterials. A biomaterial is any natural or synthetic substance engineered to interact with biological systems in order to direct 
medical treatment. Depending on the target tissue to be engineered, the biomaterial that is used must exhibit several key characteristics, such as biocompatibility or 
biodegradability, and suitable mechanical properties. Thus, biomaterials are used for a large number of applications: bone and cartilage reconstruction, cardiovascular stents, 
soft tissue sutures, nerve reconstruction and drug delivery, among others.  
INTRODUCTION: WHAT IS TERM? 
 
Polymers are long-chain molecules derived from repeating units, or monomers. Either natural or synthetic, polymers are one of the most researched biomaterials due to 
their suitable properties for many biomedical applications. Biodegradability is the property of being degradable in the presence of chemicals or enzymes in the body. 
The following hierarchical scheme classifies the biodegradable polymers analyzed in this review: 
   BIODEGRADABLE POLYMERS 
BIODEGRADABLE 
POLYMERS 
SYNTHETIC 
POLYMERS 
POLYLACTIDE (PLA) POLYGLYCOLIDE (PLG) 
POLY(LACTIDE-CO-
GLYCOLIDE) (PLGA) 
POLYPHOSPHAZENES 
SYNTHETIC/NATURAL  
POLYMERS 
POLYHYDROXY-
ALKANOATES (PHA) 
NATURAL POLYMERS 
COLLAGEN HYALURONIC ACID 
Properties: 
 - Hydrolytically degradable. 
 - It possesses chiral 
molecules. 
 - Long time to be resorbed. 
 
Applications: 
 - Long-term scaffolds for 
bone, cartilage, tendon, neural 
and vascular regeneration. 
Properties: 
 - Rapid degradation. 
 - Insolubility in common 
solvents. 
 - Hydrolytically degradable. 
 
Applications: 
 - Short-term scaffolds for 
bone, cartilage, tendon, 
tooth, vaginal, intestinal, 
lymphatic and spinal 
regeneration. 
Properties: 
 - Different properties 
depending on the Lactic 
Acid-Glycolic Acid ratio. 
 - Hydrolytically degradable. 
 
Applications: 
 - Drug delivery systems. 
 - Scaffolds for bone, 
cartilage, skin, tendon, liver 
and nerve tissue 
engineering. 
Properties: 
 - Different properties 
depending on side chain 
substitution (Figure 4). 
 - Hydrolytic degradability 
depending on the side chain 
substitution. 
 
Applications: 
 - Drug delivery systems. 
Properties: 
 - Long-time degradability. 
 - Intrinsic biocompatibility 
as it is found in cells of 
nearly all phyla. 
 - Hydrolytically degradable. 
 
Applications: 
- Long-term tissue 
engineering applications 
e.g. bone regeneration. 
Properties: 
 - Hydrolytically stable. 
 - Mechanical strength. 
 - Enzymatically degradable. 
 - Intrinsic biocompatibility 
as it is the major protein in 
human body. 
 
Applications: 
 - Scaffold for cartilage, 
tendon, ligament and skin 
regeneration. 
Properties: 
 - Intrinsic biocompatibility 
as it is one of the main 
components of body 
tissues. 
 - Enzymatically 
degradable. 
 
Applications: 
 - Hydrogels for cartilage, 
respiratory, vascular and 
nerve regeneration. 
Fig. 1: PLA scaffold for 
bone tissue regeneration. 
Fig. 2: Chemical structures of 
glycolide (1), the corresponding 
polymer PGA (3)  and the degradation 
product: glycolic acid (5).  
Fig. 3: Typical PLGA porous 
scaffolds with ear, joint, 
tube and cylinder shapes.  
Fig. 4: Simplified general 
structure of a polyphosphazene 
molecule. 
Fig. 5: Biotechnological 
production of PHA.  
Fig. 6: Cultured dermal 
substitute composed of 
spongy collagen with 
fibroblasts. 
Fig. 7: Properties of 
hyaluronic acid. 
 
 
BIOCOMPATIBILITY STUDIES 
 
The field of Tissue Engineering and Regenerative Medicine is still new and 
therefore there is still a long way before this industry becomes one of the major 
ones, which is necessary if the total variety of patients are to be attended, but 
it has a promising potential. In fact, each year the number of publications is 
increasing as new materials, applications, properties or effects are 
achieved/observed.  
 
The intergroup cooperation, the improvement of synthesis techniques, which 
can be either chemical or biotechnological depending on the biomaterial, and 
the advancements in biological research are leading to a better understanding 
of how biomaterials interact with hosts in cellular, tissue, organ and systemic 
levels. 
 
CONCLUSIONS 
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Fig. 8: Hierarchical representation of 
biocompatibility testing. 
Before the approval of a biomaterial for medical use, it has to be 
proven that it is physically suitable and harmless to the body. The 
general process can be summarized into the next key points: 
 
1) Suitable physical properties: depending on the proposed 
application different physical characteristics will be pursued and 
analyzed to determine the suitability of the analyzed material.  
 
2) In vitro cell culture systems: cell viability, adhesion, 
proliferation and differentiation are analyzed in cell cultures. 
Genotoxicity and carcinogenicity tests are also often performed. 
Cytokine secretion of macrophages and other immunologic cells 
in front of the material and/or its possible degradation products 
(local effects) are also tested in vitro. 
 
3) In vivo animal studies: inflammation capacity of the material 
can be observed in vivo in animal models (systemic effects). 
Immunogenic response of biomaterials is difficult to be studied as 
they can cause both short-term and long-term effects, as well as 
local or systemic inflammation.  
 
4) Clinical studies: This is the final and more resource-demanding 
step before the approval of the biomaterial.  
 
Note: All extracted images and information are for educational purposes only.  
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